Nauseton en es it fr

Nauseton Brand names, Nauseton Analogs

Nauseton Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Nauseton Chemical_Formula


Nauseton RX_link

No information avaliable

Nauseton fda sheet

Nauseton msds (material safety sheet)

Nauseton MSDS

Nauseton Synthesis Reference

No information avaliable

Nauseton Molecular Weight

280.285 g/mol

Nauseton Melting Point

No information avaliable

Nauseton H2O Solubility

No information avaliable

Nauseton State


Nauseton LogP


Nauseton Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Nauseton Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Nauseton Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Nauseton Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Nauseton side effects and Toxicity

No information avaliable

Nauseton Patient Information

No information avaliable

Nauseton Organisms Affected

Humans and other mammals